Middle East & Africa Vascular Closure Device Market Forecast to 2030 - Regional Analysis - by Product Type (Active Approximators, Passive Approximators, and External Hemostatic Devices), Access (Femoral Access and Radial Access), Procedure (Interventional

Middle East & Africa Vascular Closure Device Market Forecast to 2030 - Regional Analysis - by Product Type (Active Approximators, Passive Approximators, and External Hemostatic Devices), Access (Femoral Access and Radial Access), Procedure (Interventional Cardiology, Interventional Radiology, and Endovascular Surgery), and End User (Hospitals, Ambulatory Surgical Centers, and Others)

The Middle East & Africa vascular closure device market was valued at US$ 78.28 million in 2022 and is expected to reach US$ 129.04 million by 2030; it is estimated to record a CAGR of 6.4% from 2022 to 2030.

Burgeoning Demand for Minimally Invasive Devices Drives Middle East & Africa Vascular Closure Device Market

Improvements in medical science and technologies have given way to minimally invasive devices, which can aid in the replacement of traditional painful surgical methods by minimally invasive or noninvasive methods. Minimally invasive techniques have gained popularity in surgical fields such as cardiac surgery. Many of these procedures are performed using femoral cannulation for extracorporeal circulation. Vascular closure devices have gained popularity as they reduce the invasiveness and supersede surgical cut-down to cannulate the femoral artery. Vascular closure devices are mainly used in transcatheter and endovascular interventions to enable wound healing and reduce procedure time. Angiography is one of the common procedures performed in a wide variety of specialties, including vascular surgery, interventional radiology, and diagnostic and interventional cardiology. Vascular closure devices are useful in the settings of a large body habitus, anticoagulation, and antiplatelet therapies. They are also used in cases where extended bed rest may not be desirable (such as a patient with extensive pressure ulcers). A vascular closure device with resorbable collagen material, which eliminates the use of suture materials, has been introduced for transfemoral transcatheter aortic valve implantation (TAVI). For instance, the MANTA device by Teleflex Medical Inc. is adequate for the closure of arterial access sites of up to 25 Fr. Safety and efficacy of the system were demonstrated in a real-world TAVI patient cohort. Thus, the increasing demand for minimally invasive devices drives the vascular closure devices market growth.

Middle East & Africa Vascular Closure Device Market Overview

Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya are among the major countries in the Rest of the Middle East & Africa. Growing healthcare spending for better healthcare services is a significant factor contributing to the vascular closure devices market growth in the Rest of the Middle East & Africa. According to the World Bank Group, the healthcare expenditure of Kuwait and Israel is 6.31% and 8.32% of their GDP, respectively. These countries have been focusing on developing their medical device industry. Further, the high prevalence of cardiovascular diseases such as coronary artery disease and cardiac disorders in countries such as Israel, Egypt, and Lebanon propel the demand for surgical procedures. Thus, the high prevalence of cardiovascular disease and significant healthcare expenditure are the notable factors fueling the demand for minimally invasive surgical devices in the Rest of the Middle East & Africa, eventually propelling the vascular closure devices market growth.

Middle East & Africa Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Vascular Closure Device Market Segmentation

The Middle East & Africa vascular closure device market is segmented based on product type, access, procedure, end user, and country.

Based on product type, the Middle East & Africa vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share in 2022. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.

By access, the Middle East & Africa vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held a larger share in 2022.

By procedure, the Middle East & Africa vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology access segment held the largest share in 2022.

In terms of end use, the Middle East & Africa vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share in 2022.

Based on country, the Middle East & Africa vascular closure device market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa vascular closure device market in 2022.

Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, Haemonetics Corp, Medtronic Plc, and Teleflex Inc are some of the leading companies operating in the Middle East & Africa vascular closure device market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa vascular closure device market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa vascular closure device market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the vascular closure device market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

Please Note: It will take 3-5 business days to complete the report upon order confirmation for delivery of the full report and excel data pack for on demand reports.